Anal Cancer Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ACRV | F | Acrivon Therapeutics, Inc. | 0.99 | |
PDSB | F | PDS Biotechnology Corporation | 2.03 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | F | Loncar Cancer Immunotherapy ETF | 1.76 | |
IWC | C | iShares Microcap ETF | 0.04 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 0.04 | |
VTWV | C | Vanguard Russell 2000 Value ETF | 0.01 | |
VTWG | B | Vanguard Russell 2000 Growth ETF | 0.01 |
Compare ETFs
- Anal Cancer
Anal cancer is a cancer which arises from the anus, the distal opening of the gastrointestinal tract. Symptoms may include bleeding from the anus or a lump near the anus. Other symptoms may include pain, itchiness, or discharge from the anus. A change in bowel movements may also occur.Risk factors include human papillomavirus (HPV), HIV/AIDS, receptive anal sex, smoking, and many sexual partners. Anal cancer is typically a squamous cell carcinoma. Other types include adenocarcinoma, small cell carcinoma, and melanoma. Diagnosis is suspected based on physical examination and confirmed by tissue biopsy.Prevention includes avoiding risk factors and HPV vaccination. Standard treatment may include radiation therapy, chemotherapy, and surgery. About 8,300 people are diagnosed a year in the United States, representing about 0.5% of new cancers. Onset is typically after the age of 45. Women are affected more often than men. The number of cases has increased since the 1990s. The five year survival rate in the United States is 68%.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles